Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cells

Biomarkers for the clinical management of breast cancer: International perspective

(2012) Neill Patani et al.   INTERNATIONAL JOURNAL OF CANCER

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Fuel, electricity, ER and HER2—a hybrid-car model of breast cancer

(2012) Shigehira Saji et al.   Nature Reviews Clinical Oncology

Treatment of HER2-positive breast cancer: current status and future perspectives

(2011) Carlos L. Arteaga et al.   Nature Reviews Clinical Oncology

Mechanisms of Endocrine Resistance in Breast Cancer

(2010) C. Kent Osborne et al.   Annual Review of Medicine

Functional Motifs in Biochemical Reaction Networks

(2010) John J. Tyson et al.   Annual Review of Physical Chemistry

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth

(2010) Robert S. Tolhurst et al.   BREAST CANCER RESEARCH AND TREATMENT

Dysregulation of microRNAs in cancer: Playing with fire

(2010) Sonia A. Melo et al.   FEBS LETTERS

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

(2010) A Singh et al.   ONCOGENE

NF-κB and estrogen receptor α interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells

(2009) Nathalie Gionet et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours

(2009) Amy Brock et al.   NATURE REVIEWS GENETICS

Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer

(2008) Marinella Zilli et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY